Literature DB >> 18230702

Clinical pharmaceutics and calcium-ceftriaxone.

Alfred S Gin, Hannah Wheaton, Bruce Dalton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18230702     DOI： 10.1345/aph.1K410a

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Notice to Hospitals Regarding Ceftriaxone-Calcium Incompatibility: What's a Clinician to Do?

Authors:  Alfred Gin; Sandra Walker
Journal:  Can J Hosp Pharm       Date:  2009-03

2.  Survey of Canadian Pharmacists' Responses to Warnings of Potential Interactions Between Ceftriaxone and Calcium in IV Solutions.

Authors:  Curtis K Harder; John J Hawboldt
Journal:  Can J Hosp Pharm       Date:  2009-11

3.  Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practice.

Authors:  John S Esterly; Emily Steadman; Marc H Scheetz
Journal:  Int J Clin Pharm       Date:  2011-03-29

4.  Evaluation of a potential clinical interaction between ceftriaxone and calcium.

Authors:  Emily Steadman; Dennis W Raisch; Charles L Bennett; John S Esterly; Tischa Becker; Michael Postelnick; June M McKoy; Steve Trifilio; Paul R Yarnold; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.